limitations of targeted therapy for aml
Published 5 years ago • 214 plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
1:36
targeted therapy for aml
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
2:46
targeted therapies available for the treatment of patients with aml
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:13
the importance of cd47 as a target in mds and aml
-
3:15
using targeted therapies to optimize transplant outcomes in aml
-
1:44
lower-intensity frontline therapy for newly diagnosed aml
-
2:34
the evolution of the aml treatment paradigm
-
2:07
what is meant by “targeted therapy” for aml?
-
2:15
the toxicity of induction therapy in aml
-
3:37
the future of aml treatment
-
1:24
mechanisms of resistance to flt3 inhibitors in aml and strategies to overcome this
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
1:14
promising novel agents in aml: menin inhibitors
-
1:19
new treatments for aml
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
1:15
the potential of differentiation therapies for aml
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
2:18
future directions in aml: targeted therapies, antibody-radiation conjugates & new combinations